251 related articles for article (PubMed ID: 36422511)
41. The prevalence of adverse reactions among individuals with three-dose COVID-19 vaccination.
Wang Y; Zhang Y; Zhang M; Zhang X; Li H; Wang Y; Wang W; Ji J; Wu L; Zheng D
J Infect Public Health; 2023 Jan; 16(1):125-132. PubMed ID: 36516647
[TBL] [Abstract][Full Text] [Related]
42. Adverse events following third dose of mRNA COVID-19 vaccination among nursing home residents who received the primary series.
Bardenheier BH; White EM; Blackman C; Gravenstein S; Gutman R; Sarkar IN; Feifer RA; McConeghy K; Nanda A; Duprey M; Mor V
J Am Geriatr Soc; 2022 Jun; 70(6):1642-1647. PubMed ID: 35460263
[TBL] [Abstract][Full Text] [Related]
43. Intention to receive a COVID-19 vaccine booster dose and associated factors in Malaysia.
Wong LP; Alias H; Siaw YL; Muslimin M; Lai LL; Lin Y; Hu Z
Hum Vaccin Immunother; 2022 Nov; 18(5):2078634. PubMed ID: 35648441
[TBL] [Abstract][Full Text] [Related]
44. Willingness to pay for HPV vaccine among female health care workers in a Chinese nationwide survey.
Lu X; Ji M; Wagner AL; Huang W; Shao X; Zhou W; Lu Y
BMC Health Serv Res; 2022 Nov; 22(1):1324. PubMed ID: 36335333
[TBL] [Abstract][Full Text] [Related]
45. Willingness to pay for COVID-19 vaccines: Applying the health belief model.
Arabyat RM; Nusair MB; Al-Azzam SI; Amawi HA; El-Hajji FD
Res Social Adm Pharm; 2023 Jan; 19(1):95-101. PubMed ID: 36153237
[TBL] [Abstract][Full Text] [Related]
46. Efficacy, Usability, and Acceptability of a Chatbot for Promoting COVID-19 Vaccination in Unvaccinated or Booster-Hesitant Young Adults: Pre-Post Pilot Study.
Luk TT; Lui JHT; Wang MP
J Med Internet Res; 2022 Oct; 24(10):e39063. PubMed ID: 36179132
[TBL] [Abstract][Full Text] [Related]
47. Willingness to pay and financing preferences for COVID-19 vaccination in China.
Wang J; Lyu Y; Zhang H; Jing R; Lai X; Feng H; Knoll MD; Fang H
Vaccine; 2021 Apr; 39(14):1968-1976. PubMed ID: 33714653
[TBL] [Abstract][Full Text] [Related]
48. Willingness and Perceptions Regarding COVID-19 Vaccine Booster Dose in Pakistani Vaccinated Population: A Cross-Sectional Survey.
Moeed A; Najeeb H; Saleem A; Asghar MS; Rafi HM; Khattak AK; Bilal Z; Seboka BT
Front Public Health; 2022; 10():911518. PubMed ID: 35844859
[TBL] [Abstract][Full Text] [Related]
49. Dermatological adverse reactions after vaccination with BNT162b2 in a cohort of healthcare workers.
Ruiz-Villaverde R; Rivera-Izquierdo M; Gil-Villalba A; Pegalajar-García MD; Pérez-Rojas J; Soler-Iborte E; Valero-Ubierna MC
Int J Dermatol; 2022 Oct; 61(10):1289-1293. PubMed ID: 35775137
[TBL] [Abstract][Full Text] [Related]
50. Reactogenicity of Simultaneous COVID-19 mRNA Booster and Influenza Vaccination in the US.
Hause AM; Zhang B; Yue X; Marquez P; Myers TR; Parker C; Gee J; Su J; Shimabukuro TT; Shay DK
JAMA Netw Open; 2022 Jul; 5(7):e2222241. PubMed ID: 35838667
[TBL] [Abstract][Full Text] [Related]
51. Vaccination status, acceptance, and knowledge toward a COVID-19 vaccine among healthcare workers: a cross-sectional survey in China.
Li XH; Chen L; Pan QN; Liu J; Zhang X; Yi JJ; Chen CM; Luo QH; Tao PY; Pan X; Lu SY; Liu LZ; Huang HQ
Hum Vaccin Immunother; 2021 Nov; 17(11):4065-4073. PubMed ID: 34344260
[TBL] [Abstract][Full Text] [Related]
52. [Investigation of Humoral and Cellular Immunity in TOBB ETÜ Hospital Workers After Three Doses of CoronaVac Vaccination and after One Dose of Comirnaty Vaccination Following Two Doses of CoronaVac].
Özyurda F; Ardıçoğlu Akışın Y; Mert T; Poyraz B; Özkan Y; Turan M; Göçmen JS; Yücel A; Akar N
Mikrobiyol Bul; 2022 Jul; 56(3):387-403. PubMed ID: 35960233
[TBL] [Abstract][Full Text] [Related]
53. COVID-19 booster vaccine willingness.
Sønderskov KM; Vistisen HT; Dinesen PT; Østergaard SD
Dan Med J; 2021 Dec; 69(1):. PubMed ID: 34913428
[TBL] [Abstract][Full Text] [Related]
54. Why do parents willingness-to-pay to vaccinate their children against COVID-19? A real-world evidence in Taizhou, China.
Tung TH; Lin XQ; Chen Y; Wu H; Zhang MX; Zhu JS
Hum Vaccin Immunother; 2022 Dec; 18(1):1-9. PubMed ID: 35061958
[TBL] [Abstract][Full Text] [Related]
55. Factors associated with COVID-19 booster vaccine willingness among migrants from the Eastern Mediterranean living in Australia: a cross-sectional study.
Allen K; Lambert SB; Yuen A; Pourmarzi D
BMC Public Health; 2022 Nov; 22(1):2205. PubMed ID: 36443806
[TBL] [Abstract][Full Text] [Related]
56. COVID-19 Vaccine Willingness and Related Factors Among Health Care Workers in 3 Southeast Asian Jurisdictions.
Wong EL; Qiu H; Chien WT; Wong JC; Chalise HN; Hoang HT; Nguyen HT; Chan PK; Wong MC; Cheung AW; Yeoh EK
JAMA Netw Open; 2022 Aug; 5(8):e2228061. PubMed ID: 35994284
[TBL] [Abstract][Full Text] [Related]
57. Examining the uptake of COVID-19 vaccine booster doses among healthcare workers in South Africa: A mixed-methods study.
George G; Nota P; Strauss M; Lansdell E; Peters RPH; Brysiewicz P; Nadesan-Reddy N; Wassenaar D
PLOS Glob Public Health; 2023; 3(11):e0002639. PubMed ID: 37983237
[TBL] [Abstract][Full Text] [Related]
58. Acceptance of COVID-19 boosters among hypertensive patients in China: A multicenter cross-sectional study.
Yan Y; Chen Q; Nuermaimaiti A; Xiao Y; Chang L; Ji H; Sun H; Song Q; Gao Y; Xu J; Wang L
Hum Vaccin Immunother; 2023 Dec; 19(3):2283315. PubMed ID: 37982140
[TBL] [Abstract][Full Text] [Related]
59. [Antibody Response After Two Doses of Inactivated SARS-CoV-2 Vaccine in Healthcare Workers with and without Previous COVID-19 Infection: A Prospective Observational Study].
Özgür D; Tütüncü EE
Mikrobiyol Bul; 2022 Jan; 56(1):36-48. PubMed ID: 35088958
[TBL] [Abstract][Full Text] [Related]
60. Assessment of COVID-19 vaccination among healthcare workers in Iraq; adverse effects and hesitancy.
Darweesh O; Khatab N; Kheder R; Mohammed T; Faraj T; Ali S; Ameen M; Kamal-Aldin A; Alswes M; Al-Jomah N
PLoS One; 2022; 17(11):e0274526. PubMed ID: 36399454
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
